Showing results (331-340 of 432) with videos related to
Sort By:
Pageof 44
Current HIV Research|November 16, 2010
Do HIV-Infected Immigrants Initiating HAART have Poorer Treatment-Related Outcomes than Autochthonous Patients in Spain? Results of the GESIDA 5808 StudyJosé A Pérez Molina, Marta Mora Rillo, Ignacio Suárez-Lozano, et al.Current HIV Research|March 14, 2008
Patients' characteristics and clinical implications of suboptimal CD4 T-cell gains after 1 year of successful antiretroviral therapyFélix Gutiérrez, Sergio Padilla, Mar Masiá, et al.Plos One|January 27, 2022
Exposure to valproic acid is associated with less pulmonary infiltrates and improvements in diverse clinical outcomes and laboratory parameters in patients hospitalized with COVID-19Julio Collazos, Pere Domingo, Nerio Fernández-Araujo, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 13, 2025
Immune reconstitution in very advanced HIV patients treated with dolutegravir vs. darunavir-based triple antiretroviral therapy: the Advanz-4 randomized clinical trialJose M Miro, Ferran Torres, Christian Manzardo, et al.The Lancet. HIV|August 5, 2024
Identifying risk factors for anal cancer in people with HIV in Spain: a multicentre retrospective cohort study nested in the PISCIS cohortJosep M Llibre, Boris Revollo, Jordi Aceiton, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 12, 2026
Proof-of-Concept Phase 2a Trial of VH4524184 (VH-184), an Emerging Third-Generation Integrase Strand Transfer Inhibitor With an Enhanced Resistance ProfileLuise Rogg, Sebastian A Nuñez, María Verónica Mingrone, et al.The Lancet. HIV|October 16, 2021
Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort studyDaniel K Nomah, Juliana Reyes-Urueña, Yesika Díaz, et al.Enfermedades Infecciosas Y Microbiologia Clinica|April 14, 2005
[Changing trends in HIV epidemics: recent diagnoses in the Spanish VACH cohort (2000-2002)]Ramón Teira, Ignacio Suárez-Lozano, Pepa Muñoz, et al.Enfermedades Infecciosas Y Microbiologia Clinica|September 1, 2015
Costs and cost-effectiveness analysis of 2015 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adultsJuan Berenguer, Antonio Rivero, Antonio Javier Blasco, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 18, 2020
Dynamics of the Decay of Human Immunodeficiency Virus (HIV) RNA and Distribution of Bictegravir in the Genital Tract and Rectum in Antiretroviral-naive Adults Living With HIV-1 Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide (Spanish HIV/AIDS Research Network, PreEC/RIS 58)Arkaitz Imaz, Juan M Tiraboschi, Jordi Niubó, et al.Pageof 44